0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human GnRH Peptide Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29R14863
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human GnRH Peptide Market Research Report 2023
BUY CHAPTERS

Global Human GnRH Peptide Market Research Report 2025

Code: QYRE-Auto-29R14863
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human GnRH Peptide Market

The global market for Human GnRH Peptide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Human GnRH Peptide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human GnRH Peptide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human GnRH Peptide include Thermo Fisher Scientific, LSBio, Abcam, Merck Millipore, Kerafast, Abcepta, RayBiotech, Novus Biologicals, Ilex Life Sciences, Cloud - Clone, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human GnRH Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human GnRH Peptide.
The Human GnRH Peptide market size, estimations, and forecasts are provided in terms of sales volume (Kilogram) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human GnRH Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human GnRH Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human GnRH Peptide Market Report

Report Metric Details
Report Name Human GnRH Peptide Market
Segment by Type
  • Purity Less Than 95%
  • Purity 95%-98%
  • Purity Greater Than 98%
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, LSBio, Abcam, Merck Millipore, Kerafast, Abcepta, RayBiotech, Novus Biologicals, Ilex Life Sciences, Cloud - Clone, PEPTIDE INSTITUTE, MedChemExpress, Phoenix Pharmaceutical, AdooQ BioScience, IVDSHOW
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human GnRH Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human GnRH Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human GnRH Peptide Market report?

Ans: The main players in the Human GnRH Peptide Market are Thermo Fisher Scientific, LSBio, Abcam, Merck Millipore, Kerafast, Abcepta, RayBiotech, Novus Biologicals, Ilex Life Sciences, Cloud - Clone, PEPTIDE INSTITUTE, MedChemExpress, Phoenix Pharmaceutical, AdooQ BioScience, IVDSHOW

What are the Application segmentation covered in the Human GnRH Peptide Market report?

Ans: The Applications covered in the Human GnRH Peptide Market report are Endometriosis, Uterine Fibroids, Artificial Assisted Reproduction, Prostate Cancer, Central Precocious Puberty, Others

What are the Type segmentation covered in the Human GnRH Peptide Market report?

Ans: The Types covered in the Human GnRH Peptide Market report are Purity Less Than 95%, Purity 95%-98%, Purity Greater Than 98%

Recommended Reports

Peptide Drug Markets

Bioactive Peptides

Cosmetic Peptides

1 Human GnRH Peptide Market Overview
1.1 Product Definition
1.2 Human GnRH Peptide by Type
1.2.1 Global Human GnRH Peptide Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity Less Than 95%
1.2.3 Purity 95%-98%
1.2.4 Purity Greater Than 98%
1.3 Human GnRH Peptide by Application
1.3.1 Global Human GnRH Peptide Market Value by Application (2024 VS 2031)
1.3.2 Endometriosis
1.3.3 Uterine Fibroids
1.3.4 Artificial Assisted Reproduction
1.3.5 Prostate Cancer
1.3.6 Central Precocious Puberty
1.3.7 Others
1.4 Global Human GnRH Peptide Market Size Estimates and Forecasts
1.4.1 Global Human GnRH Peptide Revenue 2020-2031
1.4.2 Global Human GnRH Peptide Sales 2020-2031
1.4.3 Global Human GnRH Peptide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human GnRH Peptide Market Competition by Manufacturers
2.1 Global Human GnRH Peptide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human GnRH Peptide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human GnRH Peptide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human GnRH Peptide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human GnRH Peptide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human GnRH Peptide, Product Type & Application
2.7 Global Key Manufacturers of Human GnRH Peptide, Date of Enter into This Industry
2.8 Global Human GnRH Peptide Market Competitive Situation and Trends
2.8.1 Global Human GnRH Peptide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human GnRH Peptide Players Market Share by Revenue
2.8.3 Global Human GnRH Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human GnRH Peptide Market Scenario by Region
3.1 Global Human GnRH Peptide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human GnRH Peptide Sales by Region: 2020-2031
3.2.1 Global Human GnRH Peptide Sales by Region: 2020-2025
3.2.2 Global Human GnRH Peptide Sales by Region: 2026-2031
3.3 Global Human GnRH Peptide Revenue by Region: 2020-2031
3.3.1 Global Human GnRH Peptide Revenue by Region: 2020-2025
3.3.2 Global Human GnRH Peptide Revenue by Region: 2026-2031
3.4 North America Human GnRH Peptide Market Facts & Figures by Country
3.4.1 North America Human GnRH Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human GnRH Peptide Sales by Country (2020-2031)
3.4.3 North America Human GnRH Peptide Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human GnRH Peptide Market Facts & Figures by Country
3.5.1 Europe Human GnRH Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human GnRH Peptide Sales by Country (2020-2031)
3.5.3 Europe Human GnRH Peptide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human GnRH Peptide Market Facts & Figures by Region
3.6.1 Asia Pacific Human GnRH Peptide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human GnRH Peptide Sales by Region (2020-2031)
3.6.3 Asia Pacific Human GnRH Peptide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human GnRH Peptide Market Facts & Figures by Country
3.7.1 Latin America Human GnRH Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human GnRH Peptide Sales by Country (2020-2031)
3.7.3 Latin America Human GnRH Peptide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human GnRH Peptide Market Facts & Figures by Country
3.8.1 Middle East and Africa Human GnRH Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human GnRH Peptide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human GnRH Peptide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human GnRH Peptide Sales by Type (2020-2031)
4.1.1 Global Human GnRH Peptide Sales by Type (2020-2025)
4.1.2 Global Human GnRH Peptide Sales by Type (2026-2031)
4.1.3 Global Human GnRH Peptide Sales Market Share by Type (2020-2031)
4.2 Global Human GnRH Peptide Revenue by Type (2020-2031)
4.2.1 Global Human GnRH Peptide Revenue by Type (2020-2025)
4.2.2 Global Human GnRH Peptide Revenue by Type (2026-2031)
4.2.3 Global Human GnRH Peptide Revenue Market Share by Type (2020-2031)
4.3 Global Human GnRH Peptide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human GnRH Peptide Sales by Application (2020-2031)
5.1.1 Global Human GnRH Peptide Sales by Application (2020-2025)
5.1.2 Global Human GnRH Peptide Sales by Application (2026-2031)
5.1.3 Global Human GnRH Peptide Sales Market Share by Application (2020-2031)
5.2 Global Human GnRH Peptide Revenue by Application (2020-2031)
5.2.1 Global Human GnRH Peptide Revenue by Application (2020-2025)
5.2.2 Global Human GnRH Peptide Revenue by Application (2026-2031)
5.2.3 Global Human GnRH Peptide Revenue Market Share by Application (2020-2031)
5.3 Global Human GnRH Peptide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Human GnRH Peptide Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 LSBio
6.2.1 LSBio Company Information
6.2.2 LSBio Description and Business Overview
6.2.3 LSBio Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LSBio Human GnRH Peptide Product Portfolio
6.2.5 LSBio Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam Human GnRH Peptide Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Merck Millipore
6.4.1 Merck Millipore Company Information
6.4.2 Merck Millipore Description and Business Overview
6.4.3 Merck Millipore Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Millipore Human GnRH Peptide Product Portfolio
6.4.5 Merck Millipore Recent Developments/Updates
6.5 Kerafast
6.5.1 Kerafast Company Information
6.5.2 Kerafast Description and Business Overview
6.5.3 Kerafast Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kerafast Human GnRH Peptide Product Portfolio
6.5.5 Kerafast Recent Developments/Updates
6.6 Abcepta
6.6.1 Abcepta Company Information
6.6.2 Abcepta Description and Business Overview
6.6.3 Abcepta Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abcepta Human GnRH Peptide Product Portfolio
6.6.5 Abcepta Recent Developments/Updates
6.7 RayBiotech
6.7.1 RayBiotech Company Information
6.7.2 RayBiotech Description and Business Overview
6.7.3 RayBiotech Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 RayBiotech Human GnRH Peptide Product Portfolio
6.7.5 RayBiotech Recent Developments/Updates
6.8 Novus Biologicals
6.8.1 Novus Biologicals Company Information
6.8.2 Novus Biologicals Description and Business Overview
6.8.3 Novus Biologicals Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novus Biologicals Human GnRH Peptide Product Portfolio
6.8.5 Novus Biologicals Recent Developments/Updates
6.9 Ilex Life Sciences
6.9.1 Ilex Life Sciences Company Information
6.9.2 Ilex Life Sciences Description and Business Overview
6.9.3 Ilex Life Sciences Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ilex Life Sciences Human GnRH Peptide Product Portfolio
6.9.5 Ilex Life Sciences Recent Developments/Updates
6.10 Cloud - Clone
6.10.1 Cloud - Clone Company Information
6.10.2 Cloud - Clone Description and Business Overview
6.10.3 Cloud - Clone Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cloud - Clone Human GnRH Peptide Product Portfolio
6.10.5 Cloud - Clone Recent Developments/Updates
6.11 PEPTIDE INSTITUTE
6.11.1 PEPTIDE INSTITUTE Company Information
6.11.2 PEPTIDE INSTITUTE Description and Business Overview
6.11.3 PEPTIDE INSTITUTE Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 PEPTIDE INSTITUTE Human GnRH Peptide Product Portfolio
6.11.5 PEPTIDE INSTITUTE Recent Developments/Updates
6.12 MedChemExpress
6.12.1 MedChemExpress Company Information
6.12.2 MedChemExpress Description and Business Overview
6.12.3 MedChemExpress Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MedChemExpress Human GnRH Peptide Product Portfolio
6.12.5 MedChemExpress Recent Developments/Updates
6.13 Phoenix Pharmaceutical
6.13.1 Phoenix Pharmaceutical Company Information
6.13.2 Phoenix Pharmaceutical Description and Business Overview
6.13.3 Phoenix Pharmaceutical Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Phoenix Pharmaceutical Human GnRH Peptide Product Portfolio
6.13.5 Phoenix Pharmaceutical Recent Developments/Updates
6.14 AdooQ BioScience
6.14.1 AdooQ BioScience Company Information
6.14.2 AdooQ BioScience Description and Business Overview
6.14.3 AdooQ BioScience Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.14.4 AdooQ BioScience Human GnRH Peptide Product Portfolio
6.14.5 AdooQ BioScience Recent Developments/Updates
6.15 IVDSHOW
6.15.1 IVDSHOW Company Information
6.15.2 IVDSHOW Description and Business Overview
6.15.3 IVDSHOW Human GnRH Peptide Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IVDSHOW Human GnRH Peptide Product Portfolio
6.15.5 IVDSHOW Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human GnRH Peptide Industry Chain Analysis
7.2 Human GnRH Peptide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human GnRH Peptide Production Mode & Process Analysis
7.4 Human GnRH Peptide Sales and Marketing
7.4.1 Human GnRH Peptide Sales Channels
7.4.2 Human GnRH Peptide Distributors
7.5 Human GnRH Peptide Customer Analysis
8 Human GnRH Peptide Market Dynamics
8.1 Human GnRH Peptide Industry Trends
8.2 Human GnRH Peptide Market Drivers
8.3 Human GnRH Peptide Market Challenges
8.4 Human GnRH Peptide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human GnRH Peptide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human GnRH Peptide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human GnRH Peptide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human GnRH Peptide Sales (Kilogram) of Key Manufacturers (2020-2025)
 Table 5. Global Human GnRH Peptide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human GnRH Peptide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human GnRH Peptide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human GnRH Peptide Average Price (US$/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human GnRH Peptide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human GnRH Peptide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human GnRH Peptide, Product Type & Application
 Table 12. Global Key Manufacturers of Human GnRH Peptide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human GnRH Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human GnRH Peptide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human GnRH Peptide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human GnRH Peptide Sales by Region (2020-2025) & (Kilogram)
 Table 18. Global Human GnRH Peptide Sales Market Share by Region (2020-2025)
 Table 19. Global Human GnRH Peptide Sales by Region (2026-2031) & (Kilogram)
 Table 20. Global Human GnRH Peptide Sales Market Share by Region (2026-2031)
 Table 21. Global Human GnRH Peptide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human GnRH Peptide Revenue Market Share by Region (2020-2025)
 Table 23. Global Human GnRH Peptide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human GnRH Peptide Revenue Market Share by Region (2026-2031)
 Table 25. North America Human GnRH Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human GnRH Peptide Sales by Country (2020-2025) & (Kilogram)
 Table 27. North America Human GnRH Peptide Sales by Country (2026-2031) & (Kilogram)
 Table 28. North America Human GnRH Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human GnRH Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human GnRH Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human GnRH Peptide Sales by Country (2020-2025) & (Kilogram)
 Table 32. Europe Human GnRH Peptide Sales by Country (2026-2031) & (Kilogram)
 Table 33. Europe Human GnRH Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human GnRH Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human GnRH Peptide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human GnRH Peptide Sales by Region (2020-2025) & (Kilogram)
 Table 37. Asia Pacific Human GnRH Peptide Sales by Region (2026-2031) & (Kilogram)
 Table 38. Asia Pacific Human GnRH Peptide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human GnRH Peptide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human GnRH Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human GnRH Peptide Sales by Country (2020-2025) & (Kilogram)
 Table 42. Latin America Human GnRH Peptide Sales by Country (2026-2031) & (Kilogram)
 Table 43. Latin America Human GnRH Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human GnRH Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human GnRH Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human GnRH Peptide Sales by Country (2020-2025) & (Kilogram)
 Table 47. Middle East and Africa Human GnRH Peptide Sales by Country (2026-2031) & (Kilogram)
 Table 48. Middle East and Africa Human GnRH Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human GnRH Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human GnRH Peptide Sales (Kilogram) by Type (2020-2025)
 Table 51. Global Human GnRH Peptide Sales (Kilogram) by Type (2026-2031)
 Table 52. Global Human GnRH Peptide Sales Market Share by Type (2020-2025)
 Table 53. Global Human GnRH Peptide Sales Market Share by Type (2026-2031)
 Table 54. Global Human GnRH Peptide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human GnRH Peptide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human GnRH Peptide Revenue Market Share by Type (2020-2025)
 Table 57. Global Human GnRH Peptide Revenue Market Share by Type (2026-2031)
 Table 58. Global Human GnRH Peptide Price (US$/mg) by Type (2020-2025)
 Table 59. Global Human GnRH Peptide Price (US$/mg) by Type (2026-2031)
 Table 60. Global Human GnRH Peptide Sales (Kilogram) by Application (2020-2025)
 Table 61. Global Human GnRH Peptide Sales (Kilogram) by Application (2026-2031)
 Table 62. Global Human GnRH Peptide Sales Market Share by Application (2020-2025)
 Table 63. Global Human GnRH Peptide Sales Market Share by Application (2026-2031)
 Table 64. Global Human GnRH Peptide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human GnRH Peptide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human GnRH Peptide Revenue Market Share by Application (2020-2025)
 Table 67. Global Human GnRH Peptide Revenue Market Share by Application (2026-2031)
 Table 68. Global Human GnRH Peptide Price (US$/mg) by Application (2020-2025)
 Table 69. Global Human GnRH Peptide Price (US$/mg) by Application (2026-2031)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Scientific Human GnRH Peptide Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. LSBio Company Information
 Table 76. LSBio Description and Business Overview
 Table 77. LSBio Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 78. LSBio Human GnRH Peptide Product
 Table 79. LSBio Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 83. Abcam Human GnRH Peptide Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. Merck Millipore Company Information
 Table 86. Merck Millipore Description and Business Overview
 Table 87. Merck Millipore Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 88. Merck Millipore Human GnRH Peptide Product
 Table 89. Merck Millipore Recent Developments/Updates
 Table 90. Kerafast Company Information
 Table 91. Kerafast Description and Business Overview
 Table 92. Kerafast Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 93. Kerafast Human GnRH Peptide Product
 Table 94. Kerafast Recent Developments/Updates
 Table 95. Abcepta Company Information
 Table 96. Abcepta Description and Business Overview
 Table 97. Abcepta Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 98. Abcepta Human GnRH Peptide Product
 Table 99. Abcepta Recent Developments/Updates
 Table 100. RayBiotech Company Information
 Table 101. RayBiotech Description and Business Overview
 Table 102. RayBiotech Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 103. RayBiotech Human GnRH Peptide Product
 Table 104. RayBiotech Recent Developments/Updates
 Table 105. Novus Biologicals Company Information
 Table 106. Novus Biologicals Description and Business Overview
 Table 107. Novus Biologicals Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 108. Novus Biologicals Human GnRH Peptide Product
 Table 109. Novus Biologicals Recent Developments/Updates
 Table 110. Ilex Life Sciences Company Information
 Table 111. Ilex Life Sciences Description and Business Overview
 Table 112. Ilex Life Sciences Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 113. Ilex Life Sciences Human GnRH Peptide Product
 Table 114. Ilex Life Sciences Recent Developments/Updates
 Table 115. Cloud - Clone Company Information
 Table 116. Cloud - Clone Description and Business Overview
 Table 117. Cloud - Clone Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 118. Cloud - Clone Human GnRH Peptide Product
 Table 119. Cloud - Clone Recent Developments/Updates
 Table 120. PEPTIDE INSTITUTE Company Information
 Table 121. PEPTIDE INSTITUTE Description and Business Overview
 Table 122. PEPTIDE INSTITUTE Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 123. PEPTIDE INSTITUTE Human GnRH Peptide Product
 Table 124. PEPTIDE INSTITUTE Recent Developments/Updates
 Table 125. MedChemExpress Company Information
 Table 126. MedChemExpress Description and Business Overview
 Table 127. MedChemExpress Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 128. MedChemExpress Human GnRH Peptide Product
 Table 129. MedChemExpress Recent Developments/Updates
 Table 130. Phoenix Pharmaceutical Company Information
 Table 131. Phoenix Pharmaceutical Description and Business Overview
 Table 132. Phoenix Pharmaceutical Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 133. Phoenix Pharmaceutical Human GnRH Peptide Product
 Table 134. Phoenix Pharmaceutical Recent Developments/Updates
 Table 135. AdooQ BioScience Company Information
 Table 136. AdooQ BioScience Description and Business Overview
 Table 137. AdooQ BioScience Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 138. AdooQ BioScience Human GnRH Peptide Product
 Table 139. AdooQ BioScience Recent Developments/Updates
 Table 140. IVDSHOW Company Information
 Table 141. IVDSHOW Description and Business Overview
 Table 142. IVDSHOW Human GnRH Peptide Sales (Kilogram), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 143. IVDSHOW Human GnRH Peptide Product
 Table 144. IVDSHOW Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Human GnRH Peptide Distributors List
 Table 148. Human GnRH Peptide Customers List
 Table 149. Human GnRH Peptide Market Trends
 Table 150. Human GnRH Peptide Market Drivers
 Table 151. Human GnRH Peptide Market Challenges
 Table 152. Human GnRH Peptide Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human GnRH Peptide
 Figure 2. Global Human GnRH Peptide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human GnRH Peptide Market Share by Type: 2024 & 2031
 Figure 4. Purity Less Than 95% Product Picture
 Figure 5. Purity 95%-98% Product Picture
 Figure 6. Purity Greater Than 98% Product Picture
 Figure 7. Global Human GnRH Peptide Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Human GnRH Peptide Market Share by Application: 2024 & 2031
 Figure 9. Endometriosis
 Figure 10. Uterine Fibroids
 Figure 11. Artificial Assisted Reproduction
 Figure 12. Prostate Cancer
 Figure 13. Central Precocious Puberty
 Figure 14. Others
 Figure 15. Global Human GnRH Peptide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Human GnRH Peptide Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Human GnRH Peptide Sales (2020-2031) & (Kilogram)
 Figure 18. Global Human GnRH Peptide Average Price (US$/mg) & (2020-2031)
 Figure 19. Human GnRH Peptide Report Years Considered
 Figure 20. Human GnRH Peptide Sales Share by Manufacturers in 2024
 Figure 21. Global Human GnRH Peptide Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Human GnRH Peptide Players: Market Share by Revenue in Human GnRH Peptide in 2024
 Figure 23. Human GnRH Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Human GnRH Peptide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Human GnRH Peptide Sales Market Share by Country (2020-2031)
 Figure 26. North America Human GnRH Peptide Revenue Market Share by Country (2020-2031)
 Figure 27. United States Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Human GnRH Peptide Sales Market Share by Country (2020-2031)
 Figure 30. Europe Human GnRH Peptide Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Human GnRH Peptide Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Human GnRH Peptide Revenue Market Share by Region (2020-2031)
 Figure 38. China Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Human GnRH Peptide Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Human GnRH Peptide Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Human GnRH Peptide Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Human GnRH Peptide Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Human GnRH Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Human GnRH Peptide by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Human GnRH Peptide by Type (2020-2031)
 Figure 57. Global Human GnRH Peptide Price (US$/mg) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Human GnRH Peptide by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Human GnRH Peptide by Application (2020-2031)
 Figure 60. Global Human GnRH Peptide Price (US$/mg) by Application (2020-2031)
 Figure 61. Human GnRH Peptide Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart